Amylin Expands Manufacturing Facility in Ohio

May 10, 2007
Untitled Document

Hamilton, OH (May 2)—Amylin Ohio LLC, a subsidiary of Amylin Pharmaceuticals (San Diego, CA,, is expanding construction at its manufacturing facility in West Chester, Ohio. The expansion increases the company’s total investment to approximately $400 million.

The manufacturing facility is in the process of being equipped to manufacture the company’s long-acting release formulation of exenatide, which is being developed to treat Type-2 diabetes. The expanded facility is expected to create up to 500 jobs over the next three years.

lorem ipsum